RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Diluted EPS

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 20242.4-12.13%
Dec 31, 20232.7-58.97%
Dec 31, 20226.6+2.79%
Dec 31, 20216.5+137.13%
Dec 31, 20202.7-48.48%
Dec 31, 20195.3+44.26%
Dec 31, 20183.7+10.91%
Dec 31, 20173.3-9.09%
Dec 31, 20163.6+15.97%
Dec 31, 20153.1+184.55%
Dec 31, 20141.1-57.03%
Dec 31, 20132.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)